All health topics

Malaria

Patient education

What it is

An infection carried by mosquitoes. It is common here and it is treatable, but it can become dangerous quickly, especially in children under five and in pregnancy.

When to seek urgent care

The person is confused, very drowsy or unconscious; is having fits; cannot keep any fluid down; is breathing fast or with difficulty; passes very dark urine or has stopped passing urine; is a child under five, is pregnant, or was already unwell.

What are the facts

2024 estimatesData year · These are not live counts.

Malaria is preventable and treatable, but still takes many lives. These estimates describe the burden in 2024, not your personal chance of becoming ill.

Worldwide

282 million

Estimated malaria episodes

  • About 610,000 deaths
  • Nearly all episodes occurred in low- and middle-income countries
  • Around 96% were in sub-Saharan Africa

Low- and middle-income countries

281.7 million

Estimated malaria episodes

  • About 6.4 episodes in 100 people at risk during 2024
  • About 610,000 estimated deaths

Sub-Saharan Africa

270.7 million

Estimated malaria episodes

  • About 22.9 episodes in 100 people at risk during 2024
  • About 594,000 estimated deaths

Country comparison

Your country

Enable GPS or choose a country in the interactive reader to compare its figures with the top ten.

Young children carry a heavy burden: about 3 in 4 malaria deaths in the WHO African Region were among children younger than five.

2024 estimates

The 10 countries with the most malaria episodes

2024 estimates, ordered by total burden from highest to lowest. Each row compares cases or episodes with the matching country population. Counts remain below the country name.

  • Nigeria: 2.9 in 10 people at risk, all ages; about 68.5M episodes.
  • DR Congo: 3.2 in 10 people at risk, all ages; about 35.2M episodes.
  • Uganda: 2.6 in 10 people at risk, all ages; about 13.2M episodes.
  • Ethiopia: 1.4 in 10 people at risk, all ages; about 12.4M episodes.
  • Mozambique: 3 in 10 people at risk, all ages; about 10.2M episodes.
  • Angola: 2.6 in 10 people at risk, all ages; about 9.8M episodes.
  • Tanzania: 1.4 in 10 people at risk, all ages; about 9.4M episodes.
  • Côte d’Ivoire: 2.7 in 10 people at risk, all ages; about 8.6M episodes.
  • Mali: 3.5 in 10 people at risk, all ages; about 8.5M episodes.
  • Burkina Faso: 3.5 in 10 people at risk, all ages; about 8.3M episodes.
How to read these numbers

These are estimated episodes, not the percentage of people infected, severe cases or the chance of dying. National averages hide local differences.

Africa (African Union member states), the WHO African Region and sub-Saharan Africa have different boundaries. Income groups overlap these regions; do not add their figures together.

Estimates can change as evidence improves. Sources: WHO World malaria report 2025, African Union 2026 release and World Bank's WHO-sourced 2024 incidence series.

Additional regional context: Africa · AU member states — 96 in 100 of the world's malaria episodes occurred here: 270.8 million episodes and nearly 600,000 deaths. Source: African Union · Africa's 2024 burden.

Country ranks compare totals within the same source and year, among countries and territories with available estimates. Missing estimates and zero values are different; neither is assigned a positive-burden rank.

The United States is not endemic for malaria, but imported and occasional local cases occur. N/A in the WHO endemic-country table does not mean no malaria cases (CDC).

Population icons use matching 2024 source denominators: WHO population at risk for malaria; WHO resident population for TB; IDF adults aged 20–79 for diabetes. These are crude count-to-population ratios, not age-standardised rates. Ten icons represent the whole comparison scale; small rates are labelled per 1,000. Annual episodes are not unique people. Missing denominators remain N/A.

Regional totals and population rates are calculated from the same 2024 WHO country estimates and denominators. Group membership uses the saved World Bank Country API snapshot checked 4 November 2026, not a claim of historical 2024 income classification. Income and regional groups overlap and must not be added. Countries without comparable source estimates are excluded. The member ISO codes and exact sums are retained with this topic data.

Previous regional rate context: World Bank / WHO 2024 series reported 64.5 malaria episodes per 1,000 people at risk for LMICs and 229.3 for SSA; these can differ slightly from our matched-country sums.

Country status is separate from the 2024 burden estimates. WHO's malaria-free register and supplementary list were checked on 4 November 2026 (register updated 15 July 2025). Certification concerns interrupted indigenous transmission; imported or introduced cases may still occur. Geographic and species-specific qualifications are preserved. A zero estimate or missing value alone never establishes elimination.

The 'Low estimated burden' message for malaria means fewer than one estimated episode per 1,000 people at risk in this source and year. This is an explanatory display threshold, not a WHO transmission classification, an elimination designation, or an individual risk assessment. National averages can hide local transmission.

Sources checked 2026-11-04.

How it shows

Fever, often with chills and shaking, headache, aching body and tiredness. Children may simply be hot, refuse to eat and be unusually quiet.

What to do

Get a malaria test before taking anything. A rapid test takes about fifteen minutes and is available at most health centres and many pharmacies. Treating without testing is how people end up treating the wrong illness and missing the right one.

Ask your health centre about the current national malaria programme, eligibility and costs; availability and subsidies vary.

Why testing matters

Malaria is caused by parasites passed on by infected mosquitoes. A previous attack does not give lasting protection. Fever, chills, headache and vomiting overlap with other infections, so symptoms alone cannot confirm malaria.

A clinician uses a rapid blood test or microscopy. If the result is negative but illness continues, return for reassessment of malaria and other causes. Do not keep buying antimalarials for an unexplained fever.

Recovery and prevention

Take prescribed treatment exactly as directed, even after the fever settles. If vomiting prevents you from keeping medicine or fluids down, seek care promptly. Children and pregnant people can become seriously ill quickly.

Sleep under an insecticide-treated net, cover exposed skin in the evening and use an appropriate repellent. Before travel, ask about prevention medicines. During pregnancy, ask the antenatal team about local malaria prevention. Nets and prevention reduce risk but do not rule out malaria when a fever develops.

Sources

  1. Malaria · Public sector health information · OGL v3.0
  2. CDC: choosing malaria prevention medicine · CDC · Linked public-health reference; original AfyaMesh summary
  3. UKHSA: malaria prevention for travellers, 2026 · UK Health Security Agency · Linked public-health reference; original AfyaMesh summary
  4. CDC Yellow Book: malaria, bite prevention and returning travellers · CDC · Linked public-health reference; original AfyaMesh summary
  5. CDC: Cameroon destination recommendations · CDC · Linked public-health reference; original AfyaMesh summary
  6. Cameroon PNLP: seasonal malaria chemoprevention programme · Cameroon National Malaria Control Programme · Linked public-health reference; original AfyaMesh summary
  7. Cameroon: malaria management guidelines 2024, prevention chapter · Cameroon Ministry of Public Health · Linked public-health reference; original AfyaMesh summary
  8. Cameroon PNLP: pregnancy, child prevention and vaccination strategies · Cameroon National Malaria Control Programme · Linked public-health reference; original AfyaMesh summary
  9. WHO: preventive malaria treatment in pregnancy · WHO · Linked public-health reference; original AfyaMesh summary

Contains public sector information licensed under the Open Government Licence v3.0.

Community